Tracking the Evolution of Non-Small-Cell Lung Cancer

M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, S Veeriah, S Shafi, DH Johnson, R Mitter, R Rosenthal, M Salm, S Horswell, M Escudero, N Matthews, A Rowan, T Chambers, DA Moore, S Turajlic, H Xu, SM LeeMD Forster, T Ahmad, CT Hiley, C Abbosh, M Falzon, E Borg, T Marafioti, D Lawrence, M Hayward, S Kolvekar, N Panagiotopoulos, SM Janes, R Thakrar, A Ahmed, Fiona Blackhall, Y Summers, R Shah, L Joseph, AM Quinn, Philip Crosbie, B Naidu, G Middleton, G Langman, S Trotter, M Nicolson, H Remmen, K Kerr, M Chetty, L Gommersall, DA Fennell, A Nakas, S Rathinam, G Anand, S Khan, P Russell, V Ezhil, B Ismail, M Irvin-Sellers, V Prakash, JF Lester, M Kornaszewska, R Attanoos, H Adams, H Davies, S Dentro, P Taniere, B O'Sullivan, HL Lowe, JA Hartley, N Iles, H Bell, Y Ngai, JA Shaw, J Herrero, Z Szallasi, RF Schwarz, A Stewart, SA Quezada, J Le Quesne, P Van Loo, Caroline Dive, A. Hackshaw, C Swanton

Research output: Contribution to journalArticlepeer-review

228 Downloads (Pure)

Abstract

BACKGROUND:
Among patients with non-small-cell lung cancer (NSCLC), data on intratumor heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. We wanted to prospectively investigate intratumor heterogeneity in relation to clinical outcome and to determine the clonal nature of driver events and evolutionary processes in early-stage NSCLC.
METHODS:
In this prospective cohort study, we performed multiregion whole-exome sequencing on 100 early-stage NSCLC tumors that had been resected before systemic therapy. We sequenced and analyzed 327 tumor regions to define evolutionary histories, obtain a census of clonal and subclonal events, and assess the relationship between intratumor heterogeneity and recurrence-free survival.
RESULTS:
We observed widespread intratumor heterogeneity for both somatic copy-number alterations and mutations. Driver mutations in EGFR, MET, BRAF, and TP53 were almost always clonal. However, heterogeneous driver alterations that occurred later in evolution were found in more than 75% of the tumors and were common in PIK3CA and NF1 and in genes that are involved in chromatin modification and DNA damage response and repair. Genome doubling and ongoing dynamic chromosomal instability were associated with intratumor heterogeneity and resulted in parallel evolution of driver somatic copy-number alterations, including amplifications in CDK4, FOXA1, and BCL11A. Elevated copy-number heterogeneity was associated with an increased risk of recurrence or death (hazard ratio, 4.9; P=4.4×10-4), which remained significant in multivariate analysis.
CONCLUSIONS:
Intratumor heterogeneity mediated through chromosome instability was associated with an increased risk of recurrence or death, a finding that supports the potential value of chromosome instability as a prognostic predictor. (Funded by Cancer Research UK and others; TRACERx ClinicalTrials.gov number, NCT01888601 .).
Original languageEnglish
Pages (from-to)2109-2121
JournalThe New England Journal of Medicine
Volume376
Issue number22
Early online date26 Apr 2017
DOIs
Publication statusPublished - 1 Jun 2017

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Tracking the Evolution of Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this